Urgent call for breast cancer drug to stop women’s lives being cut short Women with HER2-low incurable secondary disease in Scotland currently have access, while others across the UK do not The Independent UK · May 23, 2024
More than a third of cancer patients in England face potentially deadly delays Overall NHS figures show 6.37 million patients waiting for health treatment at end of December The Guardian - UK · Feb 8, 2024
Cost of breast cancer to UK economy could reach £3.6bn by 2034, study shows Figure represents cost to NHS, productivity lost by society, and losses and expenses for patients The Guardian - UK · Jan 22, 2024
Almost 300,000 women to be offered drug which can reduce risk of breast cancer The drug is to be offered to post-menopausal women at moderate or high risk of breast cancer. The Independent UK · Nov 7, 2023
Ryan Reynolds and Rob McElhenney's Wrexham promotion hero lands Liverpool role The highly-qualified coach was integral to Wrexham Women's promotion campaign and will continue to feature for Reynold's and McElhenney's side while at the WSL club Daily Mirror · Jun 19, 2023
Most early-stage breast cancer patients will become long-term survivors, study finds Experts said that the majority of women with early stage breast cancer will beat the disease Evening Standard · Jun 13, 2023
First Wrexham fairy tale shows Hollywood influence is paying off as spotlight to be shone on rest of Wales Wrexham Women sealed promotion to Wales' top domestic league in style Wales Online · Apr 17, 2023
Wrexham Women make history to give Ryan Reynolds and Rob McElhenney first promotion Wrexham AFC Women’s side beat play-off rivals to win promotion back to top-flight for first time since reforming Wales Online · Apr 17, 2023
Wrexham Women make history and take huge next step as Hollywood influence pays off Wrexham Women secured promotion to the Welsh top-flight and an historic semi-professional status as they defeated Briton Ferry 1-0 in the promotion play-off final Daily Mirror · Apr 17, 2023
More women are living with secondary breast cancer, new research reveals There were 57,215 patients living with metastatic breast cancer in England in 2020/2021, up from 38,350 in 2016/2017, an estimate says. The Independent UK · Dec 22, 2022
New NHS drug offers lifeline to 1,600 women with rare aggressive form of breast cancer Experts welcomed the news that women in England will be eligible for the new immunotherapy The Independent UK · Nov 8, 2022
Breast cancer patients ‘waiting for years before reconstruction surgery’ The charity Breast Cancer Now has called for services to be put back on track. The Independent UK · Oct 18, 2022
‘Momentous milestone’: New ‘life-extending’ drug for NHS to treat breast cancer ‘This landmark decision will offer a new, effective treatment for these women, and crucially give them the hope of invaluable extra months to live,’ Baroness Delyth Morgan says The Independent UK · Jul 13, 2022
New breast cancer drugs to benefit thousands Two drugs are being made available to patients through the cancer drugs fund. The Independent UK · Jul 13, 2022
Daily Mirror · Jun 17, 2022 Thousands of women with breast cancer could benefit from new NHS-approved pill A clinical trial found that people taking the drug alongside hormone therapy had a more than 30% better chance of their cancer not coming back
The Independent UK · May 25, 2022 Women with advanced breast cancer granted new NHS drug ‘Precious additional time before their disease progresses and more months to live and spend time with loved ones,’ says campaigner
The Independent UK · May 25, 2022 New hope for women with advanced breast cancer as immunotherapy drug approved for NHS Keytruda is for women with incurable secondary triple negative breast cancer and its aim is to slow disease progression.
The Guardian - UK · May 25, 2022 Women in England with breast cancer may qualify for drug that buys ‘precious’ time Nice approves Keytruda, which with chemotherapy can lengthen survival of women with triple negative breast cancer
The Independent UK · May 24, 2022 Women with advanced breast cancer get new immunotherapy on the NHS Keytruda is for women with incurable secondary triple negative breast cancer and its aim is to slow disease progression.